Colony-Stimulating Factor Prescribing Patterns in Patients Receiving Chemotherapy for Cancer
We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines.
Read More
Preliminary Treatment Considerations Among Men With Newly Diagnosed Prostate Cancer
In a survey of local-stage prostate cancer patients, preference for prostatectomy was influenced by perceptions of its efficacy and personal burden versus nonsurgical options.
Increasing Copayments and Adherence to Diabetes, Hypertension, and Hyperlipidemic Medications
A copayment increase from $2 to $7 adversely affected veterans' adherence to statins, antihypertensives, and oral hypoglycemic agents.
Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost
Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
